Development Patents. ADCT shall have the sole right at its sole expense and in its sole discretion to control the enforcement of Development Patents under Sections 3.1.2(b) and 3.1.2(c) during the Term. In any enforcement action filed by ADCT under this Section, MedImmune agrees to be joined as a party, at ADCT’s expense, if a court of competent jurisdiction determines that it is necessary to do so.
Appears in 4 contracts
Samples: License Agreement (ADC Therapeutics SA), License Agreement (ADC Therapeutics SA), License Agreement (ADC Therapeutics SA)
